Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device may make neck pain treatment faster and less painful

NCT ID NCT05424198

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device (Trident cannula) against a standard one for treating neck pain caused by small joints in the spine. About 80 adults with long-term neck pain will receive a procedure using either device. The goal is to see if the new device works just as well but with less discomfort and shorter procedure time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2023

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult patient aged ≥18 capable of understanding and providing consent in English and capable of complying with the outcome instruments used. 2. Axial (non-radicular) neck pain for at least 3 months. 3. 7-day average numeric pain rating score (NRS) for neck pain of 4/10 or greater at baseline evaluation. 4. \*Positive responses to dual diagnostic MBB blocks using 0.5mL of lidocaine and bupivacaine, on respective encounters on separate days, at each of the appropriate MBBs. * Levels selected for diagnostic procedures will be determined by the treating physician based on the overall clinical picture including the location of pain, pain referral patterns, physical examination and imaging findings. The procedural techniques of all MBB blocks will be performed according to Spine Intervention Society guidelines.(14) A pain diary with appropriate diagnostic categories of relief will be provided (100% relief, 80-99% relief, etc.), will be provided. In order to qualify as a positive block, the subject must experience relief lasting at least one hour with lidocaine and two hours with bupivacaine. Exclusion Criteria: 1. Those receiving remuneration for their pain treatment (e.g. disability, worker's compensation, auto injury in litigation or pending litigation). 2. The patient is incarcerated. 3. Those unable to read English and complete the assessment instruments. 4. Allergy to contrast media or local anesthetics. 5. Chronic widespread pain or somatoform disorder (e.g. fibromyalgia). 6. Prior cervical medial branch radiofrequency neurotomy. 7. Severe clinical depression or psychotic features. 8. Possible pregnancy or other reason that precludes the use of fluoroscopy. 9. Daily chronic opiate use of \>50 morphine equivalents. 10. Presence of pacemaker of neurostimulator. 11. Systemic infection at time of procedure. 12. Uncontrolled bleeding diathesis. 13. Requirement of IV procedural sedation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical facet joint pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Neck Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Utah Farmington Health Center

    Farmington, Utah, 84025, United States

  • University of Utah Orthopaedic Center

    Salt Lake City, Utah, 84108, United States

  • University of Utah South Jordan Health Center

    South Jordan, Utah, 84009, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.